Thermo Fisher Scientific INC Form 4 insider transactions

Michael D Shafer, Executive Vice President of Thermo Fisher Scientific Inc., sold 25,500 shares of common stock on August 11, 2026 for $600.00 per share.

Lisa P. Britt, Sr. VP and Chief HR Officer of Thermo Fisher Scientific Inc., sold 5,850 shares of common stock on August 6, 2026 for $580.00 per share.

Marc N Casper, Chairman & CEO and a Director of Thermo Fisher Scientific Inc., sold 15,000 shares of common stock on August 6, 2026.

Marc N Casper, Chairman & CEO and a Director of Thermo Fisher Scientific Inc., sold 15,000 shares of common stock on August 5, 2026.

Gianluca Pettiti, President & COO of Thermo Fisher Scientific Inc., sold 400 shares of common stock on July 27, 2026 for $565.00 per share.

Thermo Fisher Scientific Inc. reports a director, Scott M. Sperling, acquired stock units under the company's Deferred Compensation Plan for Directors.

Thermo Fisher Scientific Inc. director Keith R. Alexandra acquired stock units under the company's Deferred Compensation Plan for Directors.

Thermo Fisher Scientific Inc. director Dion J. Weisler acquired phantom stock units under the company's Deferred Compensation Plan for Directors.

Thermo Fisher Scientific Director Karen S. Lynch acquired phantom stock units under the company's Deferred Compensation Plan for Directors.

Jennifer M. Johnson, a Director at Thermo Fisher Scientific, acquired phantom stock units valued at $60.91 on June 27, 2026, under the company's Deferred Compensation Plan for Directors.

Director Dion J. Weisler reported a net increase in his holdings of Thermo Fisher Scientific common stock following a tax-related disposition and a stock grant.

Thermo Fisher Scientific director Scott M. Sperling acquired 499 shares of common stock as part of a compensation grant.

Thermo Fisher Scientific director Debora L. Spar acquired 499 shares of common stock as part of a routine equity grant.

Thermo Fisher Scientific director Karen S. Lynch acquired 499 shares of common stock as part of a routine equity grant.

Thermo Fisher Scientific director R. Alexandra Keith acquired 499 shares of common stock as part of a compensation grant.

Thermo Fisher Scientific director Jennifer M. Johnson acquired 499 shares of common stock as part of a routine equity grant.

Thermo Fisher Scientific Director Tyler Jacks acquired 499 shares of common stock on May 20, 2026, increasing his direct beneficial ownership to 9,462 shares.

Thermo Fisher Scientific director C. Martin Harris acquired 499 shares of common stock as part of a routine equity grant.

Director Nelson Chai acquired 499 shares of Thermo Fisher Scientific Inc. common stock as part of a director compensation grant.

Thermo Fisher Scientific Director Scott M. Sperling is scheduled to acquire 89.78 phantom stock units on March 28, 2026, through the company's deferred compensation plan.

Thermo Fisher Scientific Director R. Alexandra Keith acquired 66.02 phantom stock units valued at $473.36 each under the company's deferred compensation plan.

Thermo Fisher Scientific Director Karen S. Lynch acquired 66.02 phantom stock units through the company's deferred compensation plan.

Jennifer M. Johnson, a director at Thermo Fisher Scientific, acquired 66.02 phantom stock units through a deferred compensation plan.

Thermo Fisher Scientific Director Dion J. Weisler acquired 79.22 phantom stock units under the company's deferred compensation plan.

Thermo Fisher Scientific Inc. Chairman and CEO Marc N. Casper executed pre-planned sales of common stock totaling 10,000 shares after exercising stock options.

Thermo Fisher Scientific's Sr. VP and Chief HR Officer, Lisa P. Britt, disposed of common stock to cover tax withholding obligations.

Joseph R. Holmes, VP & Chief Accounting Officer at Thermo Fisher Scientific, reported the disposition of 116.626 shares of common stock for tax purposes.

Stephen Williamson, retiring Sr. VP and CFO of Thermo Fisher Scientific, disposed of common stock shares to cover tax liabilities.

Thermo Fisher Scientific's Executive Vice President, Michael D. Shafer, reported the disposition of 815.848 shares of common stock on February 28, 2026, for tax purposes.

Frederick M. Lowery, Executive Vice President at Thermo Fisher Scientific, reported planned sales of common stock totaling 896.968 shares under a Rule 10b5-1 plan.